(Q46974104)

27 December 2017

title

Single- and multiple-dose pharmacokinetics of pirfenidone, an antifibrotic agent, in healthy Chinese volunteers (English)

1 reference

27 December 2017

1 reference

Shaojun Shi

1

1 reference

27 December 2017

Jianhong Wu

2

1 reference

27 December 2017

Huating Chen

3

1 reference

27 December 2017

Hui Chen

4

1 reference

27 December 2017

Jun Wu

5

1 reference

27 December 2017

Fandian Zeng

6

1 reference

27 December 2017

publication date

1 October 2007

1 reference

27 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

27 December 2017

volume

47

1 reference

27 December 2017

issue

10

1 reference

27 December 2017

page(s)

1268-1276

1 reference

27 December 2017

Drug treatments for idiopathic pulmonary fibrosis

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

Treatment of idiopathic pulmonary fibrosis: is there anything new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

Lung fibrosis is ameliorated by pirfenidone fed in diet after the second dose in a three-dose bleomycin-hamster model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

Pirfenidone inhibits inflammatory responses and ameliorates allograft injury in a rat lung transplant model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

Effect of pirfenidone against vanadate-induced kidney fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

Pirfenidone inhibits dimethylnitrosamine-induced hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

Pirfenidone effectively reverses experimental liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

The anti-fibrotic effect of pirfenidone in rat liver fibrosis is mediated by downregulation of procollagen alpha1(I), TIMP-1 and MMP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

Open-label study of pirfenidone in patients with progressive forms of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

A double-blind, randomized, controlled study of oral pirfenidone for treatment of secondary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

Pharmacokinetics and metabolism of a novel antifibrotic drug pirfenidone, in mice following intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

Pharmacokinetics of orally administered pirfenidone in male and female beagles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

Pharmacokinetics of an antifibrotic agent, pirfenidone, in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

The effects of food on drug bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

21 January 2018

Food-drug interactions

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

Effects of food on clinical pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

The effect of food on drug bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007304104

21 January 2018

Identifiers

DOI

10.1177/0091270007304104

1 reference

27 December 2017

PubMed ID

17906160

1 reference

27 December 2017